Chemours Reaches $450 Million PFAS Settlement with EPA Over Pollution Claims in Three States

The Chemours Company has reached a settlement with the US Environmental Protection Agency, the Department of Justice, and the West Virginia Department of Environmental Protection to resolve claims linked to PFAS releases from several of its manufacturing facilities. The agreement, announced on June 24, 2026, is described by federal authorities as the first comprehensive federal settlement with a major PFAS manufacturer.

The settlement is estimated to exceed $450 million in penalties and injunctive relief. It covers facilities in Washington Works, West Virginia; Fayetteville Works, North Carolina; Chambers Works, New Jersey; and Parlin, New Jersey. According to the EPA, Chemours allegedly released per- and polyfluoroalkyl substances, known as PFAS, into the Ohio River, Cape Fear River, and Delaware River, in some cases without required permits and in other cases in violation of permit conditions.

PFAS are a large group of synthetic chemicals used in applications requiring resistance to water, grease, heat, or stains. They are widely used in industrial processes and consumer products, but are often referred to as “forever chemicals” because they persist in the environment and can accumulate over time. The EPA said PFAS do not break down easily in the environment or the human body and have been linked to serious health risks.

Settlement Covers CWA, TSCA and Hazardous Waste Claims

The settlement resolves Chemours’ alleged liability under the Clean Water Act, the Resource Conservation and Recovery Act, the Toxic Substances Control Act, and the West Virginia Water Pollution Control Act. The EPA said the alleged Clean Water Act violations included releasing certain PFAS without National Pollutant Discharge Elimination System permits, releasing PFAS in violation of permits, and failing to comply with permit conditions.

The agreement also addresses alleged TSCA violations associated with restrictions on PFAS releases to air and water at the four facilities. According to the EPA’s settlement summary, these included alleged failures to include relevant information in a premanufacture notice, violations of recordkeeping provisions under a TSCA section 5(e) order, and unlawful manufacturing and processing of PFAS outside an enclosed process.

In addition, the settlement resolves alleged hazardous waste violations under RCRA, including accepting shipments of hazardous waste in violation of a permit and unauthorized storage of hazardous waste. The Department of Justice said the alleged violations continued for more than a decade, while noting that the settlement does not resolve DuPont’s liability for PFAS linked to facilities previously owned by DuPont.

Financial Terms and Pollution Controls

Under the agreement, Chemours will pay a civil penalty of $22.5 million, assessed by federal authorities based on the company’s ability to pay. The company will also carry out a multi-year, government-supervised $90 million PFAS mitigation program.

The EPA said Chemours will spend more than $337 million on injunctive relief, including an estimated $280 million to provide alternative drinking water, $60 million to support legal compliance at its West Virginia facility, and additional funds for compliance measures at other facilities. The company must also complete 14 treatment system projects to reduce PFAS in wastewater, stormwater, and groundwater at its West Virginia plant.

The consent decree requires Chemours to control releases of GenX, a PFAS compound used in fluoropolymer production, from each facility at an efficiency of at least 99%. Chemours must also test drinking water and provide treated or alternative water to communities near its plants in West Virginia and New Jersey, implement enhanced leak detection programs, conduct engineering reviews, and certify proper hazardous waste storage.

At the company’s North Carolina facility, Chemours will be required to evaluate options and implement controls to reduce releases of PFAS and other toxic chemicals based on recommendations from an independent engineering firm. This is particularly relevant because the Fayetteville Works site has been central to long-running concerns over PFAS contamination in the Cape Fear River watershed.

Company Response and Compliance Implications

Chemours said the agreement provides greater clarity on future compliance requirements and recognizes operational improvements and remedial measures already completed or underway across its sites. The company expects to pay the $22.5 million civil penalty in three annual installments in 2026, 2027, and 2028, beginning within 30 days of court approval of the consent decree.

Chemours also said the $90 million in mitigation projects will be funded over the next 15 years and will support its target to reduce process emissions of fluorinated organic chemicals by 99% or more by 2030. The company stated that the settlement forms part of its broader strategy to address legacy PFAS and environmental claims.

For manufacturers, the case illustrates the growing compliance and financial risks linked to PFAS production, use, discharge, and waste handling. It also shows how regulators are using multiple legal frameworks together, including water, chemicals, and hazardous waste laws, to address contamination across air, water, groundwater, and drinking water systems.

The settlement may also influence how companies evaluate legacy chemical liabilities in mergers, spin-offs, supply chains, and environmental due diligence. PFAS-related liabilities can extend beyond direct emissions, affecting drinking water provision, remediation reserves, permitting, product stewardship, and disclosures to investors.

Broader Significance for Sustainability and Net-Zero Strategies

Although PFAS regulation is not usually framed as a climate issue, it is increasingly relevant to sustainability governance. Companies pursuing net-zero targets are also under pressure to demonstrate credible management of broader environmental impacts, including water quality, chemical safety, waste management, and community exposure risks.

The Chemours settlement underscores that environmental performance cannot be limited to emissions accounting. Industrial companies with climate transition plans may face scrutiny if decarbonization strategies are not matched by robust controls for toxic substances, hazardous waste, and local pollution. For investors and corporate sustainability teams, this creates a wider compliance landscape where climate, chemicals, water, and human health risks are increasingly connected.

The proposed consent decree has been filed with the US District Court for the Southern District of West Virginia and remains subject to a 30-day public comment period and final court approval.

Source: www.esgdive.com